Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06798480

Prevalence of Problematic Use of Social Media

In 2023, French individuals spend an average of two hours per day on social media platforms (SM), primarily Facebook, TikTok, X, YouTube, Instagram, and Snapchat. While social media offers undeniable benefits, it also raises concerns about its impact on mental health and well-being. These impacts remain poorly understood, partly due to the diversity of social media uses and motivations, which do not have uniform effects on health. For instance, studies have shown that "active" use of social media (e.g., content creation) is associated with higher well-being, whereas "passive" use (e.g., content scrolling) is linked to lower well-being.

This challenge in understanding the variety of social media uses and their consequences has direct clinical implications. Clinicians working in pediatrics, child psychiatry, and addiction medicine are increasingly confronted with patients struggling to manage their social media use. However, they lack clear diagnostic criteria to differentiate between normal and problematic use, as well as specific tools tailored to address potential disorders.

Moreover, in France, there is no existing estimate of the proportion of the general population affected by problematic social media use.

This study aims to establish the prevalence of problematic use of social media in France. The investigators hypothesize that the prevalence will be close to 10%, which is the prevalence that has been found in other European countries in previous studies.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

13 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospices Civils de Lyon

Lyon, 69003, France

Location contact

Julia DE TERNAY, Dr

CONTACT

[email protected]

+33 04 72 11 78 52 ext. +33

Julia DE TERNAY, Dr

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 13 years or older.
  • Resident in France and French-speaking.
  • Does not object to participating in the study, and, for minors, whose parents also do not object to their participation.

Exclusion criteria

  • Unable to understand and complete the questionnaire (e.g., non-French-speaking).

Treatment and study plan

Self-administered survey

Other

An anonymous self-administered online questionnaire hosted on LimeSurvey, lasting approximately 20 minutes, will be completed by participants. A panel of participants representative of the general population will be provided by the Selvitys Institute. In parallel, the self-administered questionnaire will also be distributed via posts on social media platforms (Facebook, YouTube, Instagram, TikTok, Snapchat, and X) over a period of three months.

Primary outcomes

  1. Prevalence of problematic use of social media.

    Time frame: baseline

    Outcome measure: Problematic use will be identified if the participant endorses at least 6 out of 9 items on the French version of the Social Media Addiction Scale. The prevalence of problematic use will be calculated as the number of participants with problematic use divided by the total number of participants.

Study contacts

Contact information is provided by the study sponsor or research team.

Julia DE TERNAY, Dr

CONTACT

[email protected]

+33 04 72 11 78 52 ext. +33

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Prevalence of Problematic Use of Social Media in the General PopuLation

Acronym: PURPLE

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jan 29, 2025
Registry last updated
Mar 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.